In a virtual hearing in Newark, N.J., Purdue Pharma admitted it didn’t maintain an effective program to prevent illegal drug distribution and that it provided misleading information to the Drug Enforcement Administration.
The drugmaker also admitted to paying kickbacks to physicians to induce them to write more opioid prescriptions. The kickbacks were made in the form of a speakers program, according to the report.
The guilty plea comes one week after bankruptcy Judge Robert Drain approved Purdue Pharma’s $8.3 billion civil settlement with the U.S. Justice Department.
The Stamford, Conn.-based drugmaker filed for Chapter 11 bankruptcy protection last year, citing mounting legal liability.
More articles on opioids:
Congressmen urge Justice Department to revise Purdue Pharma settlement
Indivior to pay $289M in criminal penalties for Suboxone marketing
Medical students harbor stigma against patients with substance abuse disorders, study suggests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.